Cognitive changes in patients with unipolar TRD treated with IV ketamine: A systematic review.
Progress in neuro-psychopharmacology & biological psychiatry December 20, 2024 Veronica Grasso, Gilmar Gutierrez, Najat Alzbeidi et al. 9 citations
Unipolar treatment-resistant depression (MDD-TRD) is associated with neurocognitive impairment. Ketamine, an emerging treatment for MDD-TRD, may have neurocognitive benefits, but evidence remains limited. We conducted a systematic search on EMBASE, Google Scholar, PsycINFO, and PubMed and included studies exploring the cognitive effects of intravenous (IV) ketamine treatment in the management...